SCHEMBL5154663

SCHEMBL5154663

CC(C)(C)OC(=O)NCCCCCC(=O)Nc1nc2ccc(OS(=O)(=O)c3ccccc3)cc2s1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.51
RAB9A P51151 4/20 0.51
MAPT P10636 5/20 0.50
GAA P10253 2/20 0.50
MAPK1 P28482 1/20 0.50
HDAC8 Q9BY41 3/20 0.49
HDAC6 Q9UBN7 3/20 0.49
HDAC1 Q13547 2/20 0.49
HDAC3 O15379 1/20 0.49
HDAC4 P56524 1/20 0.49
HDAC7 Q8WUI4 1/20 0.49
HDAC2 Q92769 1/20 0.49
HDAC10 Q969S8 1/20 0.49
HDAC11 Q96DB2 1/20 0.49
HDAC9 Q9UKV0 1/20 0.49
HDAC5 Q9UQL6 1/20 0.49
RXFP1 Q9HBX9 1/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
KDM4E B2RXH2 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4399513 0.92 HDAC8 (0.50) NPC1RAB9AMAPTHDAC8HDAC6
SCHEMBL4402216 0.92 HDAC8 (0.50) NPC1RAB9AMAPTHDAC8HDAC6
SCHEMBL4403568 0.92 HDAC8 (0.50) NPC1RAB9AMAPTHDAC8HDAC6
SCHEMBL4409524 0.87 HDAC8 (0.45) NPC1RAB9AMAPTHDAC8HDAC6
SCHEMBL4399550 0.87 HDAC8 (0.45) NPC1RAB9AMAPTHDAC8HDAC6
SCHEMBL4404852 0.87 HDAC8 (0.45) NPC1RAB9AMAPTHDAC8HDAC6
SCHEMBL4399546 0.87 HDAC8 (0.45) NPC1RAB9AMAPTHDAC8HDAC6
SCHEMBL31203407 0.85 NPC1 (0.63) NPC1RAB9AMAPTGAAHDAC8
SCHEMBL31203536 0.82 MAPT (0.66) NPC1RAB9AMAPTMAPK1HDAC8
SCHEMBL31203375 0.81 PTPN1 (0.53) NPC1RAB9AMAPTHDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1745044-A2 BENZOTHIAZOLE DERIVATIVES HAVING CDK MODULATING ACTIVITY AND USE THEREOF AS ANTICANCER AGENTS Aventis Pharma S.A. (FR) 2007-01-24 EP disclosed
WO-2005097787-A2 NOVEL BENZOTHIAZOLES AND THE USE THEREOF AS MEDICAMENTS AVENTIS PHARMA S.A. (FR) 2005-10-20 WO disclosed